📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 56 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
56
இன்று
168,757
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,902
நேர்மறை
8,496
எதிர்மறை
100,558
நடுநிலை
9,733
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
245 அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: STAR
நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Strides Pharma Q3FY26: Record EBITDA of ₹2,359m; Operational PAT Surges 39% YoY

Strides Pharma Science Limited delivered its highest-ever quarterly EBITDA of ₹2,359 million in Q3FY26, marking a 12.2% YoY increase. While total revenue grew modestly by 3.6% to ₹11,946 million, operational PAT saw a significant jump of 38.6% YoY to ₹1,282 million. The performance was bolstered by a 280bps expansion in gross margins to 61.2% and a 20% YoY growth in Ex-US markets. Additionally, the company reduced its net debt to ₹13,527 million on a constant currency basis while funding ₹2,836 million in capex during 9MFY26.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Strides Pharma Q3 PAT Surges 131% YoY to ₹2,081 Million; Revenue Up 3.5%

Strides Pharma Science Limited reported a robust performance for Q3 FY26, with consolidated Profit After Tax (PAT) more than doubling to ₹2,081.22 million from ₹900.40 million in the previous year. Revenue from operations grew steadily to ₹11,946.46 million, while Profit Before Tax (PBT) before exceptional items saw a massive jump of 115% YoY. The bottom line was significantly bolstered by a surge in 'Other Income' to ₹1,068.62 million and a 17% reduction in finance costs. For the nine-month period ended December 2025, the company has achieved a PAT of ₹4,452.39 million.

நடுநிலை தாக்கம் 8/10 நிதி முடிவுகள்

Blue Star Q3 FY26 Revenue Grows 4% to ₹2,925 Cr; EBITDA Rises to ₹221 Cr

Blue Star reported a 4.2% YoY increase in Q3 FY26 revenue to ₹2,925 crore, while EBITDA grew by 5.7% to ₹221 crore. Net profitability was significantly impacted by a one-time exceptional charge of ₹56 crore related to new labor code requirements for gratuity and leave encashment, leading to an EPS drop to ₹3.92 from ₹6.44. The Room AC segment saw a revival in demand ahead of energy-label changes, while the projects segment remains strong with demand from data centers and factories.

நடுநிலை தாக்கம் 8/10 நிதி முடிவுகள்

Blue Star Q3FY26 Revenue Up 4.2% to Rs 2,925 Cr; Net Profit Hit by Exceptional Item

Blue Star reported a modest 4.2% YoY revenue growth to Rs 2,925.31 crore for Q3FY26, while EBITDA margins remained stable at 7.5%. Reported Net Profit declined to Rs 80.55 crore from Rs 132.46 crore, primarily due to a non-recurring exceptional charge of Rs 56.35 crore related to new Labour Code provisions. The Room Air Conditioner segment showed signs of revival ahead of energy label changes, though the Commercial Refrigeration market remained muted. The company's order book stands at Rs 6,898.74 crore, providing visibility despite a 16.5% drop in quarterly order inflows for the Projects segment.

நடுநிலை தாக்கம் 8/10 நிதி முடிவுகள்

Blue Star Q3FY26 Revenue Up 4.2% to Rs 2925 Cr; Net Profit Dips 39% on Exceptional Labour Cost

Blue Star reported a modest 4.2% YoY revenue growth to Rs 2925.31 crores for Q3FY26, while operating profit grew 5.4% to Rs 220.72 crores. However, Net Profit fell significantly by 39.2% to Rs 80.55 crores, primarily due to a one-time non-recurring exceptional charge of Rs 56.35 crores related to new Labour Code provisions. The Room AC segment saw inventory building ahead of energy-label changes, while the projects segment faced margin pressure due to lower-margin infrastructure projects. Despite the profit dip, the order book remains healthy at Rs 6898.74 crores, and management maintains a positive outlook for Q4.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நடுநிலை தாக்கம் 8/10 நிதி முடிவுகள்

Blue Star Q3 Revenue Up 4.2% to ₹2925 Cr; PAT Impacted by ₹56 Cr Exceptional Item

Blue Star reported a modest 4.2% YoY revenue growth to ₹2925.31 crores for Q3FY26, while operating profit grew 5.4% to ₹220.72 crores. The bottom line was significantly impacted by a one-time exceptional provision of ₹56.35 crores for gratuity and leave encashment following new Government Labour Codes. The Room AC segment benefited from channel inventory building ahead of mandatory energy-label transitions. While the company moved from a net cash to a net debt position of ₹352 crores, management expressed optimism for a strong Q4FY26 performance.

நேர்மறை தாக்கம் 7/10 நிர்வாகம்

Blue Star Re-appoints MD B Thiagarajan and Appoints New Executive & Independent Directors

Blue Star has announced a significant leadership transition, re-appointing Mr. B Thiagarajan as Managing Director for a term ending May 24, 2027. The company is strengthening its consumer business by appointing Mr. Mohit Sud, an HUL veteran with over 20 years of experience, as Executive Director for Unitary Cooling Products for a 5-year term. Additionally, Mr. M S Unnikrishnan, former MD & CEO of Thermax, joins the board as an Independent Director for 5 years. These appointments follow the completion of Mr. Sam Balsara's tenure as an Independent Director on January 31, 2026.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Star Health Q3 FY26 PAT Surges 414% YoY to ₹449 Cr; Combined Ratio Improves to 98.9%

Star Health reported a massive 414% YoY growth in Profit After Tax (PAT) to ₹449 crore for Q3 FY26, driven by strong premium growth and improved operational efficiency. The Gross Written Premium (GWP) grew 23% YoY to ₹5,047 crore, with the retail segment showing a robust 27% growth. A significant improvement was seen in the Combined Ratio, which dropped to 98.9% from 102.1% a year ago, primarily due to a 301 bps reduction in the Loss Ratio. Investment income also played a crucial role, jumping 176% YoY to ₹569 crore.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Star Health 9M FY26 PAT Jumps 87% to ₹966 Cr; Combined Ratio Improves to 99.8%

Star Health reported a robust 87% YoY increase in Profit After Tax (PAT) to ₹966 crore for 9M FY26, supported by higher investment income and improved underwriting. Gross Written Premium (GWP) rose 16% to ₹13,856 crore, with the core retail segment growing at 20%. The combined ratio improved to 99.8% from 102.1% YoY, reflecting better expense management and lower loss ratios. However, fresh GWP from the bancassurance channel declined by 8% during the period.

எதிர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Star Health Q3 FY26 PAT Drops 40% YoY to ₹128 Cr Despite 16.5% Premium Growth

Star Health and Allied Insurance reported a significant 40.4% year-on-year decline in Profit After Tax (PAT) to ₹128.22 crore for the quarter ended December 31, 2025. While Gross Written Premium grew by 16.5% to ₹4,423.43 crore, the bottom line was pressured by a rising combined ratio, which reached 94.31% compared to 92.51% in the previous year. On a positive note, the claims ratio improved to 68.55% from 70.30% YoY. The company also announced the reclassification of two promoter group entities with zero shareholding to the public category.

எதிர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

FIVESTAR Q3FY26: AUM Grows 16% YoY to ₹1.29 Lakh Cr; Asset Quality Weakens as GNPA Hits 3.18%

Five-Star Business Finance reported a 16% YoY growth in Assets Under Management (AUM) reaching ₹1,29,641 Mn for Q3FY26. However, Profit After Tax (PAT) growth was muted at just 1% YoY (₹2,770 Mn) due to a significant deterioration in asset quality. Gross Stage 3 assets (GNPA) rose sharply to 3.18% from 1.62% a year ago, and 30+ DPD increased to 12.81%. While the company continues its physical expansion with 835 branches, profitability metrics like ROA and ROE have seen notable compression.

எதிர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Five-Star Business Finance Q3 PAT at ₹277 Cr; GNPA Rises to 3.18% Amid Collection Focus

Five-Star Business Finance reported a modest 1% YoY PAT growth to ₹277 Cr for Q3FY26, while AUM grew 16% YoY to ₹12,964 Cr. Asset quality saw significant pressure as Gross Stage 3 assets spiked to 3.18% from 1.62% YoY, leading management to intentionally reduce disbursements by 18% QoQ to focus on collections. Despite the asset quality stress, the company maintained a healthy RoA of 7.00% and saw a sharp improvement in the cost of incremental debt to 8.19%. The company is aggressively expanding its collection vertical, nearly doubling its collection officer headcount YoY to 2,452.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

IndoStar Capital Finance Raises ₹500 Crore via Private Placement of NCDs

IndoStar Capital Finance Limited has completed the allotment of 50,000 Non-Convertible Debentures (NCDs) to raise INR 500 crore through a private placement. The issuance is structured across three series with coupon rates of 8.85%, 8.90%, and 9.10%, maturing between May 2028 and January 2029. These instruments are secured by a first pari-passu charge on the company's loan receivables and portfolio assets. This capital infusion will likely support the NBFC's growth objectives and liquidity management.

நேர்மறை தாக்கம் 6/10 நிர்வாகம்

IndoStar Appoints Shivam Choudhary as CTO and Amit Kothari as Chief AI Officer

IndoStar Capital Finance has announced a strategic leadership shuffle in its technology division effective January 20, 2026. Mr. Shivam Choudhary, a veteran with 19 years of experience in IT and fintech innovation, has been appointed as the new Chief Technology Officer. Simultaneously, the former CTO, Mr. Amit Kothari, has been re-designated as the Chief AI Officer. This move underscores the company's commitment to digital transformation and the integration of artificial intelligence into its financial services operations.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

Prostarm Declared L-1 Bidder for SAIL's 2 MW Roof Top Solar Project Worth ₹6.71 Cr

Prostarm Info Systems Limited has been declared the lowest (L-1) bidder by Steel Authority of India Limited (SAIL) for a solar energy project. The contract involves the supply, installation, and commissioning of a 2 MW (AC) Roof Top Solar PV System at SAIL's Burnpur Plant in West Bengal. The total consideration for this domestic order is approximately ₹6.71 Crores. The project is scheduled for completion within a 12-month timeframe.

நேர்மறை தாக்கம் 6/10 நிர்வாகம்

Megastar Foods Appoints Industry Veteran Vipin Kumar as Chief Operating Officer

Megastar Foods Limited has appointed Mr. Vipin Kumar as the Chief Operating Officer (COO) and Senior Management Personnel, effective January 6, 2026. Mr. Kumar is a Chartered Accountant with approximately 28 years of extensive experience in the agro and food business sectors. His background includes significant expertise in business and strategic development, which is expected to strengthen the company's operational leadership. This appointment follows the recommendation of the Nomination and Remuneration Committee to bolster the senior management team.

கண்காணிப்பு தாக்கம் 6/10 ஒழுங்குமுறை

Prostarm Shareholders Approve Expansion of Borrowing and Investment Limits via Postal Ballot

Prostarm Info Systems Limited has successfully passed four key special resolutions through a postal ballot with over 99.99% majority support. These resolutions authorize the company to increase its borrowing limits beyond standard thresholds and to create charges or mortgages on company assets to secure such debt. Additionally, shareholders approved the company's ability to provide loans, guarantees, and make investments exceeding the limits specified under Sections 185 and 186 of the Companies Act, 2013. This provides the management with significant financial flexibility for future capital requirements and strategic corporate actions.

நேர்மறை தாக்கம் 7/10 விரிவாக்கம்

Prostarm to Set Up New UPS Manufacturing Unit in Gujarat with Rs 6 Crore Investment

Prostarm Info Systems Limited has announced the establishment of a new manufacturing facility in Bakrol, Gujarat, dedicated to assembling Uninterruptible Power Supply (UPS) systems. The project involves an estimated capital expenditure of Rs 6 Crores, covering plant, machinery, and civil construction. The facility will produce UPS units ranging from 1KVA to 600 KVA to strengthen the company's manufacturing footprint. Commercial production is targeted to commence by May 2026, funded through a mix of internal accruals and IPO proceeds.

நேர்மறை தாக்கம் 7/10 மற்றவை

IndoStar Sells ₹135.73 Cr Stressed CV Loan Portfolio to Phoenix ARC

IndoStar Capital Finance has offloaded a portion of its Commercial Vehicle loan book to Phoenix ARC Private Limited to reduce its stressed portfolio. The transaction involves outstanding dues of Rs. 135.73 crores for a purchase consideration of up to Rs. 108.55 crores. This resolution, completed on December 29, 2025, follows RBI's Master Directions on Transfer of Loan Exposures. The move is expected to improve the company's overall asset quality by removing non-performing or stressed assets from the balance sheet.

நேர்மறை தாக்கம் 7/10 ஒழுங்குமுறை

Megastar Foods Credit Rating Upgraded to Investment Grade CARE BBB-; Stable

CARE Ratings has upgraded Megastar Foods Limited's credit rating from CARE BB+ to CARE BBB- (Stable), moving the company into the investment-grade category. This upgrade affects bank facilities totaling ₹241 crore and is based on the company's improved operational and financial performance during FY25 and H1FY26. Additionally, short-term ratings were upgraded from CARE A4+ to CARE A3, reflecting enhanced liquidity and debt-servicing capacity. This transition typically allows for better access to capital and potentially lower interest costs.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்